DOBUTAMINE BAXTER 12.5 MGML
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DOBUTAMINE AS HYDROCHLORIDE
Available from:
DAVID MARGALIT & CO.LTD
ATC code:
C01CA07
Pharmaceutical form:
CONCENTRATE FOR SOLUTION FOR INFUSION
Composition:
DOBUTAMINE AS HYDROCHLORIDE 12.5 MG/ML
Administration route:
I.V
Prescription type:
Required
Manufactured by:
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, INDIA
Therapeutic area:
DOBUTAMINE
Therapeutic indications:
Dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure.
Authorization date:
2018-05-01
